Platelet-Derived Growth Factor as an Antidepressant Treatment Selection Biomarker: Higher Levels Selectively Predict Better Outcomes with Bupropion-SSRI Combination

BACKGROUND: Platelet derived growth factor is integral to maintenance of blood brain barrier, increases in response to blood brain barrier disruption, and may reflect neuroinflammation. Based on previous reports of better outcomes with dopaminergic antidepressants in depressed patients with elevated...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Neuropsychopharmacol
Hlavní autoři: Jha, Manish K, Minhajuddin, Abu, Gadad, Bharathi S, Trivedi, Madhukar H
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2017
Témata:
Regular Research Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5737519/
https://ncbi.nlm.nih.gov/pubmed/29016822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyx060
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky